New Research Publication Sheds Light on Metastatic HR+/HER2- Breast Cancer Market Dynamics and 2032 Forecast
January 24, 2024 10:38 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032" report has been added to ResearchAndMarkets.com's...
United States KISQALI (Ribociclib; LEE011) Drug Market Insights and Forecasts Report, 2019-2022 & 2023-2032
February 15, 2023 07:43 ET
|
Research and Markets
Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "United States KISQALI Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering."KISQALI Drug...
United States IBRANCE (Palbociclib) Drug Insight and Market Forecasts Report 2023-2032
February 14, 2023 08:03 ET
|
Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "IBRANCE Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering."IBRANCE Drug Insight and Market...
Global SERD Therapeutics Market Report 2021: Opportunities with SERDs as Combination Therapy & Therapeutic Potential in Different Types of Cancers
April 27, 2021 07:58 ET
|
Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Global SERD Therapeutics Market 2019-2030: Focus on Product, Therapy, Country Data (14 Countries), and Competitive Landscape" report has been added to...